2018
Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes
Cecchini M, Walther Z, Sklar JL, Bindra RS, Petrylak DP, Eder JP, Goldberg SB. Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes. The Lancet Oncology 2018, 19: 23-24. PMID: 29304353, DOI: 10.1016/s1470-2045(17)30916-6.Peer-Reviewed Case Reports and Technical Notes
2011
Molecular Tumor Profiling for Prediction of Response to Anticancer Therapies
Walther Z, Sklar J. Molecular Tumor Profiling for Prediction of Response to Anticancer Therapies. The Cancer Journal 2011, 17: 71-79. PMID: 21427550, DOI: 10.1097/ppo.0b013e318212dd6d.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsMolecular tumor profilingTumor profilingPredictive markerLikelihood of responsePrediction of responseTreatment of cancerIndividual tumorsTumorsPredictive testingTherapyAnticancer therapyGenomic alterationsPrincipal markerMarkersDrugsPersonalized medicineHigh-throughput testingSignal transduction pathwaysAlterations